Using clinical data and a meta-analysis, high AREG and EREG mRNA expression levels were found to be associated with both progression-free and overall survival of patients with metastatic colorectal cancer treated with Cetuximab-based chemotherapy [45]. This evidence concerns the gene EREG and metastatic colorectal cancer.